US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Franklin Genomic Advancements ETF

43.62

-1.5742-3.48%

Volume:3K

Turnover:110.17K

Market Cap:32.72M

PE:- -

High:43.76

Open:43.66

Low:43.62

Close:45.20

52wk High:45.20

52wk Low:31.44

Shares:750.00K

Float Shares:750.00K

Volume Ratio:0.12

T/O Rate:0.34%

Dividend:0.14

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Guardant Health initiated with a Buy at Rothschild & Co Redburn

Natera initiated with a Buy at Rothschild & Co Redburn

Krystal Biotech CEO Krish S. Krishnan Sells USD 7.59 Million in Common Shares

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

Guardant Health Announces Landmark FDA Approval of Guardant360® Cdx as Companion Diagnostic for AstraZeneca’s Etcamah™ (Camizestrant) in Advanced Breast Cancer

THOMSON REUTERS

Natera CEO Steven Leonard Chapman Disposes of 1,698 Common Shares for $545,441.02

Krystal Biotech to Speak at Cantor Global Healthcare Conference Fireside Chat

Genedrive to Host ShareSoc Investor Webinar as Precision Diagnostics Roll Out in NHS

Precision Biology Reshapes Nutrition: Expert Discusses Tech-Driven Solutions for Every Life Stage

Guardant Health Price Target Maintained with a $195.00/Share by BTIG

Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Guardant Health (GH)

Guardant Health Shield Blood Test Wins Carelon Coverage for Colorectal Cancer Screening

Natera announces publication of new data in Blood Neoplasia on Signatera

CytoDyn Net Loss Widens to $42.7 Million in FY26

Is Ligand Pharmaceuticals (LGND) Undervalued On Its Conference Appearance?

Simply Wall St.

Does Guardant Health’s (GH) Patent Appeal Reshape Its Competitive Moat More Than Its Royalty Bill?

Simply Wall St.

Adaptive Biotechnologies Director Katey Einterz Owen Sells 9,615 Shares for $249,990

Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer

THOMSON REUTERS

Adaptive Biotechnologies (ADPT), Why Is It Getting Fresh Attention Now?

Simply Wall St.

ABL Diagnostics Calls Shareholder Vote on Move to Euronext Growth and Name Change

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/HELX/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HELX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","market":"US","secType":"STK","nameCN":"Franklin Genomic Advancements ETF","latestPrice":43.621,"timestamp":1791313113170,"preClose":45.1952,"halted":0,"volume":2520,"delay":0,"changeRate":-0.03483113250964699,"floatShares":750000,"shares":750000,"eps":0,"marketStatus":"Trading","change":-1.5742,"latestTime":"10-06 14:58:49 EDT","open":43.66,"high":43.76,"low":43.621,"amount":110173.25843999999,"amplitude":0.003076,"askPrice":43.2,"askSize":600,"bidPrice":43.04,"bidSize":600,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791316800000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":45.1952,"sharesOutstanding":650000,"nav":43.859,"aum":32894030.1,"dividendRate":0.003313,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":43.79,"preClose":45.1952,"latestTime":"16:10 EDT","volume":7,"amount":313.556,"timestamp":1791231005654,"change":-1.4052,"changeRate":-0.031092,"amplitude":0},"volumeRatio":0.117977,"impliedVol":0.1226,"impliedVolPercentile":0.5139},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","floatShares":750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.117977,"shares":750000,"dividePrice":0.1445,"high":43.76,"amplitude":0.003076,"preClose":45.1952,"low":43.621,"week52Low":31.44,"pbRate":"--","week52High":45.1952,"institutionHeld":0,"latestPrice":43.621,"eps":0,"divideRate":0.003313,"volume":2520,"delay":0,"ttmEps":0,"open":43.66,"prevYearClose":36.3062,"prevWeekClose":43.79,"prevMonthClose":44.5641,"prevQuarterClose":44.5641,"fiveDayClose":44.4008,"twentyDayClose":41.6426,"sixtyDayClose":39.7282},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HELX\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HELX","amount":0.14334,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Franklin Genomic Advancements ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-08"},{"market":"US","date":"2021-12-30","symbol":"HELX","amount":0.003935,"defaultRemindTime":1640874600000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000},{"market":"US","date":"2021-12-13","symbol":"HELX","amount":0.114148,"defaultRemindTime":1639405800000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2021-12-21","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2020-12-14","symbol":"HELX","amount":0.005005,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2020-12-23","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HELX\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-23","value":0.005005,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-21","value":0.114148,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.003935,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-08","value":0.14334,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HELX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HELX\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665532615","title":"Guardant Health initiated with a Buy at Rothschild & Co Redburn","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665532615?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:16","pubTimestamp":1788858969,"startTime":"0","endTime":"0","summary":"Rothschild & Co Redburn initiated coverage of Guardant Health (GH) with a Buy rating and $203 price target The firm says Guardant is the leader in ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-initiated-with-a-buy-at-rothschild-co-redburn-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-initiated-with-a-buy-at-rothschild-co-redburn-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","HELX","EKG","LU0109394709.USD","BK4551","LU0889565916.HKD","PTH","BK4196","BK4535","BK4588","FFOX","GDOC","GNMX","LU0320765992.SGD","BK4585","GNOM","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326489","title":"Natera initiated with a Buy at Rothschild & Co Redburn","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326489","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326489?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:15","pubTimestamp":1788858958,"startTime":"0","endTime":"0","summary":"Rothschild & Co Redburn initiated coverage of Natera (NTRA) with a Buy rating and $385 price target Natera is the market leader in molecular residu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/natera-initiated-with-a-buy-at-rothschild-co-redburn-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/natera-initiated-with-a-buy-at-rothschild-co-redburn-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1064131342.USD","LU2065170008.USD","LU0345770993.USD","LU2065731478.USD","HELX","LU2065169927.USD","LU2065171402.SGD","LU2264538146.SGD","GNOM","LU0963586101.USD","LU1988902786.USD","LU2324357040.USD","LU2065171311.SGD","LU0106261612.USD","LU0053671581.USD","BK4139","NTRA","LU0345770308.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665352961","title":"Krystal Biotech CEO Krish S. Krishnan Sells USD 7.59 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665352961","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665352961?lang=en_us&edition=fundamental","pubTime":"2026-09-05 07:15","pubTimestamp":1788563709,"startTime":"0","endTime":"0","summary":"Krystal Biotech CEO Krish S. Krishnan sells USD 7.59 million in common sharesKrish S. Krishnan, president, CEO, director, sold 25,000 Krystal Biotech common shares on Sept. 4, 2026.Sales prices cluste","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL3bqQgC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Krystal Biotech CEO Krish S. Krishnan Sells USD 7.59 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","HELX","BK4139","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354019","title":"Guardant announces FDA approval of Guardant360 CDx as companion diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354019","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354019?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:15","pubTimestamp":1788560112,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that the U.S. Food and Drug Administration has approved Guardant360 CDx as a companion diagnostic to identify patien...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","GNMX","PTH","LABU","HELX","EKG","PINK","BMED","FRTY","IBB","LU0109394709.USD","BK4585","GH","RSPH","GDOC","LU0320765992.SGD","PSCH","BK4535","BBP","MRNX","TECB","IDNA","NVIB","LU0889565916.HKD","IYH","LFSC","MRNY","SYNB","GNOM","XLVX","BK4196","IEIH","BK4588","TBXU","FFOX","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354794","title":"Guardant Health Announces Landmark FDA Approval of Guardant360® Cdx as Companion Diagnostic for AstraZeneca’s Etcamah™ (Camizestrant) in Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354794?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:10","pubTimestamp":1788559800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nTUA7GZLSJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EKG","LU0109394709.USD","LU0320765992.SGD","BK4588","BK4551","GH","GNMX","HELX","LU0889565916.HKD","GNOM","BK4585","BK4196","PTH","LFSC","BK4535","FFOX","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664388837","title":"Natera CEO Steven Leonard Chapman Disposes of 1,698 Common Shares for $545,441.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388837","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664388837?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:05","pubTimestamp":1788483934,"startTime":"0","endTime":"0","summary":"Natera CEO Steven Leonard Chapman disposes of 1,698 common shares for $545,441.02Natera CEO and President Steven Leonard Chapman sold 1,698 common shares on Sept. 1, 2026 at USD 320.99.Directly held s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL5mjfcg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera CEO Steven Leonard Chapman Disposes of 1,698 Common Shares for $545,441.02","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770308.USD","LU2065169927.USD","LU0012050646.USD","HELX","LU0106261612.USD","LU0053671581.USD","NTRA","LU1064131342.USD","LU2065171402.SGD","BK4139","LU2264538146.SGD","LU0963586101.USD","LU0345770993.USD","LU2065170008.USD","LU2065731478.USD","LU2324357040.USD","LU1988902786.USD","GNOM","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871013","title":"Krystal Biotech to Speak at Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871013","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871013?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:07","pubTimestamp":1788437263,"startTime":"0","endTime":"0","summary":"Krystal Biotech to speak at Cantor Global Healthcare Conference fireside chatKrystal Biotech will participate in the 2026 Cantor Global Healthcare Conference on Sept. 10, 2026, in New York.Management ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL65Fmjd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","HELX","KRYS","LU2210149790.SGD","PSCH","SG9999014013.SGD","LU0314104364.USD","BK4112","IE00BN0W2V16.EUR","NDAQ","BK4588","SG9999014005.SGD","IE00BQXX3D17.EUR","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","BK4139","IE00BQXX3F31.USD","IE00B64PRP62.GBP","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664821933","title":"Genedrive to Host ShareSoc Investor Webinar as Precision Diagnostics Roll Out in NHS","url":"https://stock-news.laohu8.com/highlight/detail?id=2664821933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664821933?lang=en_us&edition=fundamental","pubTime":"2026-09-03 14:09","pubTimestamp":1788415784,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Genedrive ( ($GB:GDR) ). Genedrive plc, a UK-based point-of-care pharmacogenetic testing specialist, develops r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genedrive-to-host-sharesoc-investor-webinar-as-precision-diagnostics-roll-out-in-nhs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genedrive-to-host-sharesoc-investor-webinar-as-precision-diagnostics-roll-out-in-nhs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WDNA","GNMX","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142600737","title":"Precision Biology Reshapes Nutrition: Expert Discusses Tech-Driven Solutions for Every Life Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=1142600737","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142600737?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:00","pubTimestamp":1788343237,"startTime":"0","endTime":"0","summary":"At the recently concluded second Precision Nutrition Industry Conference held in Harbin from August 21st to 23rd, a central theme emerged: how biotechnology can empower the creation of high-quality...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818611","title":"Guardant Health Price Target Maintained with a $195.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818611","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818611?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:52","pubTimestamp":1788342720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LFSC","GNMX","BK4535","GH","BK4196","GDOC","BK4585","EKG","FFOX","GNOM","PTH","BK4588","BK4551","LU0320765992.SGD","LU0109394709.USD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664863257","title":"Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664863257","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664863257?lang=en_us&edition=fundamental","pubTime":"2026-09-02 01:40","pubTimestamp":1788284405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT) and Guardant Health (GH) with bullis...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-medtronic-mdt-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-medtronic-mdt-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0208291251.USD","LU2028103732.USD","LU0889565916.HKD","PTH","IE000M9KFDE8.USD","GDOC","LU0976567544.SGD","LU1506573853.SGD","LFSC","LU1291159041.SGD","HELX","LU0109394709.USD","XBI","LU1571399168.USD","LU0158827781.USD","IE00BFXG1179.USD","LU0128526141.USD","LU1244550221.USD","FFOX","LU1983299246.USD","LU1989764748.USD","LU0320765489.SGD","IE00B3PB1722.GBP","LU0211326755.USD","LABU","EKG","IE00BQXX3C00.GBP","XLV","LU2023251221.USD","GNMX","LU2089283258.USD","LU0211331839.USD","IE00BQXX3F31.USD","LU0432979614.USD","MDT","LU1989771016.USD","LU2089284900.SGD","LU2271345857.HKD","LU0029874061.USD","LU0265550946.USD","BK4535","LU0106261372.USD","LU0162691827.USD","HCSG","LU1061106388.HKD","LU0072461881.USD","LU1116320737.USD","GNOM","GH","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856780","title":"Guardant Health Shield Blood Test Wins Carelon Coverage for Colorectal Cancer Screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856780","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856780?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:06","pubTimestamp":1788264367,"startTime":"0","endTime":"0","summary":"Guardant Health Shield blood test wins Carelon coverage for colorectal cancer screeningGuardant Health secured Carelon Healthcare Services coverage for its FDA-approved Shield blood test for colorecta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL9hPZ6Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4535","BK4551","GNOM","LU0109394709.USD","BK4588","LU0889565916.HKD","GNMX","PTH","EKG","FFOX","LU0320765992.SGD","BK4196","GDOC","GH","LFSC","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853895","title":"Natera announces publication of new data in Blood Neoplasia on Signatera","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853895","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853895?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:25","pubTimestamp":1788258359,"startTime":"0","endTime":"0","summary":"Natera (NTRA) announced the publication of new data in Blood Neoplasia, validating the prognostic and predictive value of Signatera in patients wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/natera-announces-publication-of-new-data-in-blood-neoplasia-on-signatera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/natera-announces-publication-of-new-data-in-blood-neoplasia-on-signatera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065731478.USD","LU2065171402.SGD","LU2065171311.SGD","NTRA","HELX","BK4139","LU2324357040.USD","LU2065170008.USD","LU0053671581.USD","LU0106261612.USD","LU1064131342.USD","LU0012050646.USD","LU0345770993.USD","LU2065169927.USD","LU1988902786.USD","LU0963586101.USD","GNOM","LU0345770308.USD","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663039950","title":"CytoDyn Net Loss Widens to $42.7 Million in FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2663039950","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663039950?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:35","pubTimestamp":1788179703,"startTime":"0","endTime":"0","summary":"CytoDyn net loss widens to $42.7 million in FY26CytoDyn posted a net loss of $42.7 million, swinging from net income of $3.7 million a year earlier.Operating loss widened to $38.6 million as operating","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLbc0jH6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","LU0345770308.USD","LU0345770993.USD","LU2065171402.SGD","LU2065169927.USD","GNOM","CYDY","LU2264538146.SGD","LU2065731478.USD","LU0963586101.USD","LU2065170008.USD","LU1988902786.USD","NTRA","LU2324357040.USD","LU0053671581.USD","LU0012050646.USD","LU2065171311.SGD","HELX","LU0106261612.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044806","title":"Is Ligand Pharmaceuticals (LGND) Undervalued On Its Conference Appearance?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044806","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044806?lang=en_us&edition=fundamental","pubTime":"2026-08-30 19:23","pubTimestamp":1788089019,"startTime":"0","endTime":"0","summary":"Conference appearance puts focus on Ligand Pharmaceuticals stock\nLigand Pharmaceuticals (LGND) is set to present at the 17th Annual Midwest IDEAS Conference in Chicago on 26 August 2026 at 9:15 a.m., drawing attention to its business model and recent share performance.\nRecent trading has been slightly softer around the conference, with the share price down 1.42% over the past day and 2.45% over the past month. However, Ligand Pharmaceuticals still shows strong momentum with a 47.54% year to...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lgnd/ligand-pharmaceuticals/news/is-ligand-pharmaceuticals-lgnd-undervalued-on-its-conference","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lgnd/ligand-pharmaceuticals/news/is-ligand-pharmaceuticals-lgnd-undervalued-on-its-conference","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0566484027.USD","IE0009354923.USD","LU1559883803.SGD","LGND","BK4139","HELX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044590","title":"Does Guardant Health’s (GH) Patent Appeal Reshape Its Competitive Moat More Than Its Royalty Bill?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044590","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044590?lang=en_us&edition=fundamental","pubTime":"2026-08-30 19:19","pubTimestamp":1788088793,"startTime":"0","endTime":"0","summary":"In August 2026, Guardant Health said it would appeal a US District Court of Delaware final judgment in a patent dispute with TwinStrand Biosciences and the University of Washington, with execution of the judgment and collection of potential royalties paused during the appeal.\nThe court’s royalty order applies mainly to older Guardant tests, while Guardant reports that upgraded versions of key products such as Shield and Reveal, along with validated design changes to Guardant360, fall outside...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/does-guardant-healths-gh-patent-appeal-reshape-its-competiti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/does-guardant-healths-gh-patent-appeal-reshape-its-competiti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0320765992.SGD","GNMX","GNOM","PTH","BK4585","LFSC","BK4588","BK4551","BK4196","EKG","GDOC","FFOX","BK4535","HELX","LU0109394709.USD","LU0889565916.HKD","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663168840","title":"Adaptive Biotechnologies Director Katey Einterz Owen Sells 9,615 Shares for $249,990","url":"https://stock-news.laohu8.com/highlight/detail?id=2663168840","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663168840?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:50","pubTimestamp":1787953835,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies director Katey Einterz Owen sells 9,615 shares for $249,990Adaptive Biotechnologies director Katey Einterz Owen sold 9,615 common shares on Aug. 26, 2026 at USD 26.Directly he","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL80PDl0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Adaptive Biotechnologies Director Katey Einterz Owen Sells 9,615 Shares for $249,990","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT","BK4121","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662594094","title":"Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662594094","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662594094?lang=en_us&edition=fundamental","pubTime":"2026-08-28 23:03","pubTimestamp":1787929380,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUABNSJHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1064131342.USD","LU2065170008.USD","LU0345770993.USD","LU2065731478.USD","HELX","LU2065169927.USD","LU2065171402.SGD","LU2264538146.SGD","GNOM","LU0963586101.USD","LU1988902786.USD","LU2324357040.USD","LU2065171311.SGD","LU0106261612.USD","LU0053671581.USD","BK4139","NTRA","LU0345770308.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662055660","title":"Adaptive Biotechnologies (ADPT), Why Is It Getting Fresh Attention Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662055660","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662055660?lang=en_us&edition=fundamental","pubTime":"2026-08-28 11:26","pubTimestamp":1787887617,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies (ADPT) has drawn fresh investor attention after its recent share price performance, with the stock last closing at $26.44. The move puts a spotlight on how the company’s immune medicine platform and cancer diagnostics business are currently valued.\nFor context, Adaptive Biotechnologies has shown strong momentum recently, with a 17.41% 1 month share price return, a 74.52% 3 month share price return and a 98.65% 1 year total shareholder return. Together, these figures...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adpt/adaptive-biotechnologies/news/adaptive-biotechnologies-adpt-why-is-it-getting-fresh-attent","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adpt/adaptive-biotechnologies/news/adaptive-biotechnologies-adpt-why-is-it-getting-fresh-attent","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","HELX","ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084970","title":"ABL Diagnostics Calls Shareholder Vote on Move to Euronext Growth and Name Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084970","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084970?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:37","pubTimestamp":1787848643,"startTime":"0","endTime":"0","summary":"An update from ABL Diagnostics SA ( ($FR:ABLD) ) is now available. ABL Diagnostics SA, a publicly listed French molecular diagnostics group, provid...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abl-diagnostics-calls-shareholder-vote-on-move-to-euronext-growth-and-name-change?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abl-diagnostics-calls-shareholder-vote-on-move-to-euronext-growth-and-name-change?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","ABLD","HELX","GNMX","HTEC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}